245 related articles for article (PubMed ID: 27556699)
1. Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation.
Kim EH; Kim YH; Song HS; Jeong YK; Lee JY; Sung J; Yoo SH; Yoon M
Oncotarget; 2016 Sep; 7(38):62267-62279. PubMed ID: 27556699
[TBL] [Abstract][Full Text] [Related]
2. Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives.
Zhu P; Zhu JJ
Chin Clin Oncol; 2017 Aug; 6(4):41. PubMed ID: 28841803
[TBL] [Abstract][Full Text] [Related]
3. Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis.
Kim EH; Song HS; Yoo SH; Yoon M
Oncotarget; 2016 Oct; 7(40):65125-65136. PubMed ID: 27556184
[TBL] [Abstract][Full Text] [Related]
4. Case of glioblastoma patient treated with tumor treating fields therapy at recurrence degenerating to sarcoma.
Majd P; O'Connell DE; Kim RC; Bota DA; Carrillo JA
CNS Oncol; 2017 Apr; 6(2):89-94. PubMed ID: 28303729
[TBL] [Abstract][Full Text] [Related]
5. Tumor Treating Fields in Neuro-Oncological Practice.
Mrugala MM; Ruzevick J; Zlomanczuk P; Lukas RV
Curr Oncol Rep; 2017 Aug; 19(8):53. PubMed ID: 28664468
[TBL] [Abstract][Full Text] [Related]
6. Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.
Mittal S; Klinger NV; Michelhaugh SK; Barger GR; Pannullo SC; Juhász C
J Neurosurg; 2018 Feb; 128(2):414-421. PubMed ID: 28298023
[TBL] [Abstract][Full Text] [Related]
7. Tumour Treating Fields (TTFs) for recurrent and newly diagnosed glioblastoma multiforme.
Mirza FA; Shamim MS
J Pak Med Assoc; 2018 Oct; 68(10):1543-1545. PubMed ID: 30317361
[TBL] [Abstract][Full Text] [Related]
8. The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes.
Rehman AA; Elmore KB; Mattei TA
Neurosurg Focus; 2015 Mar; 38(3):E14. PubMed ID: 25727223
[TBL] [Abstract][Full Text] [Related]
9. Tumor Treating Fields Utilization in a Glioblastoma Patient with a Preexisting Cardiac Pacemaker: The First Reported Case.
McClelland S; Henrikson CA; Ciporen JN; Jaboin JJ; Mitin T
World Neurosurg; 2018 Nov; 119():58-60. PubMed ID: 30064027
[TBL] [Abstract][Full Text] [Related]
10. Tumor treating field therapy in combination with bevacizumab for the treatment of recurrent glioblastoma.
Omar AI
J Vis Exp; 2014 Oct; (92):e51638. PubMed ID: 25407354
[TBL] [Abstract][Full Text] [Related]
11. Tumor treating fields (TTF) treatment enhances radiation-induced apoptosis in pancreatic cancer cells.
Jo Y; Oh G; Gi Y; Sung H; Joo EB; Lee S; Yoon M
Int J Radiat Biol; 2020 Dec; 96(12):1528-1533. PubMed ID: 33074042
[TBL] [Abstract][Full Text] [Related]
12. Application of tumor treating fields for newly diagnosed glioblastoma: understanding of nationwide practice patterns.
McClelland S; Sosanya O; Mitin T; Degnin C; Chen Y; Attia A; Suh JH; Jaboin JJ
J Neurooncol; 2018 Oct; 140(1):155-158. PubMed ID: 29987746
[TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibition of glioma cell proliferation by Withaferin A and tumor treating fields.
Chang E; Pohling C; Beygui N; Patel CB; Rosenberg J; Ha DH; Gambhir SS
J Neurooncol; 2017 Sep; 134(2):259-268. PubMed ID: 28681243
[TBL] [Abstract][Full Text] [Related]
14. Tumor treating fields in pediatric high-grade glioma.
Green AL; Mulcahy Levy JM; Vibhakar R; Hemenway M; Madden J; Foreman N; Dorris K
Childs Nerv Syst; 2017 Jul; 33(7):1043-1045. PubMed ID: 28470383
[TBL] [Abstract][Full Text] [Related]
15. BK K+ channel blockade inhibits radiation-induced migration/brain infiltration of glioblastoma cells.
Edalat L; Stegen B; Klumpp L; Haehl E; Schilbach K; Lukowski R; Kühnle M; Bernhardt G; Buschauer A; Zips D; Ruth P; Huber SM
Oncotarget; 2016 Mar; 7(12):14259-78. PubMed ID: 26893360
[TBL] [Abstract][Full Text] [Related]
16. Tumor treating fields therapy device for glioblastoma: physics and clinical practice considerations.
Lok E; Swanson KD; Wong ET
Expert Rev Med Devices; 2015; 12(6):717-26. PubMed ID: 26513694
[TBL] [Abstract][Full Text] [Related]
17. The combination of tumor treating fields and hyperthermia has synergistic therapeutic effects in glioblastoma cells by downregulating STAT3.
Jo Y; Han YI; Lee E; Seo J; Oh G; Sung H; Gi Y; Kim H; Park S; Yoon M
Am J Cancer Res; 2022; 12(3):1423-1432. PubMed ID: 35411245
[TBL] [Abstract][Full Text] [Related]
18. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.
Stupp R; Wong ET; Kanner AA; Steinberg D; Engelhard H; Heidecke V; Kirson ED; Taillibert S; Liebermann F; Dbalý V; Ram Z; Villano JL; Rainov N; Weinberg U; Schiff D; Kunschner L; Raizer J; Honnorat J; Sloan A; Malkin M; Landolfi JC; Payer F; Mehdorn M; Weil RJ; Pannullo SC; Westphal M; Smrcka M; Chin L; Kostron H; Hofer S; Bruce J; Cosgrove R; Paleologous N; Palti Y; Gutin PH
Eur J Cancer; 2012 Sep; 48(14):2192-202. PubMed ID: 22608262
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of tumor treating fields therapy for high-grade gliomas.
Shah PP; White T; Khalafallah AM; Romo CG; Price C; Mukherjee D
J Neurooncol; 2020 Jul; 148(3):433-443. PubMed ID: 32578135
[TBL] [Abstract][Full Text] [Related]
20. Tumour Treating Fields (TTFs) for Paediatric Brain Tumours, Brain Metastases and other Novel Applications.
Mirza FA; Shamim MS
J Pak Med Assoc; 2018 Nov; 68(11):1729-1731. PubMed ID: 30410163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
